CAS: 1791420-09-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Dilpacimab REF: TM-T77157CAS: 1791420-09-1 | - - - | To inquire | Fri 25 Oct 24 |
 | Dilpacimab REF: 3D-CLA1529CAS: 1791420-09-1 | - - - | To inquire | Mon 04 Nov 24 |
Dilpacimab
CAS:1791420-09-1
Dilpacimab (ABT165) is a dual-target antibody for DLL4 and VEGF, used in cancer research.
Color and Shape:
Solid
Ref: TM-T77157
| 5mg | To inquire |
Estimated delivery in United States, on Friday 25 Oct 2024
Dilpacimab
CAS:1791420-09-1
A humanized dual-variable domain antibody targets both delta-like ligand 4 (DLL4) and VEGF pathways
Ref: 3D-CLA1529
| Undefined size | To inquire |
Estimated delivery in United States, on Monday 4 Nov 2024
